• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紫杉醇类似物的设计、合成及生物活性研究新进展

Recent advances in design, synthesis and bioactivity of paclitaxel-mimics.

作者信息

Wen Guan, Qu Xiao-Xia, Wang Dan, Chen Xing-Xiu, Tian Xin-Chuan, Gao Feng, Zhou Xian-Li

机构信息

Department of Chinese Traditional Herbal, Agronomy College, Sichuan Agriculture University, Chengdu 611130, PR China.

Department of Chinese Traditional Herbal, Agronomy College, Sichuan Agriculture University, Chengdu 611130, PR China.

出版信息

Fitoterapia. 2016 Apr;110:26-37. doi: 10.1016/j.fitote.2016.02.010. Epub 2016 Feb 22.

DOI:10.1016/j.fitote.2016.02.010
PMID:26906104
Abstract

Taxane-type anticancer drugs, including paclitaxel and its semi-synthetic derivatives docetaxel and cabazitaxel, are widely applied to chemotherapy of malignancy like breast cancer, ovarian cancer, non-small cell lung cancer and prostate cancer. However, their clinical applications are generally limited by scarce natural resources, various side effects and multidrug resistance. Therefore, it is significant to develop paclitaxel-mimics with simplified structure, fewer side effects and improved pharmaceutical properties. Based on our investigation on chemistry of paclitaxel, the current review summarized the most recent advances in the design, synthesis and biological activities of paclitaxel-mimics, which could be appealing to researchers in the field of medicinal chemistry and oncology. Meanwhile, smart design, interesting synthesis and potential bioactivities of these novel compounds may also provide valuable reference for the wider scientific communities.

摘要

紫杉烷类抗癌药物,包括紫杉醇及其半合成衍生物多西他赛和卡巴他赛,广泛应用于乳腺癌、卵巢癌、非小细胞肺癌和前列腺癌等恶性肿瘤的化疗。然而,它们的临床应用通常受到自然资源稀缺、各种副作用和多药耐药性的限制。因此,开发结构简化、副作用更少且药学性质改善的紫杉醇类似物具有重要意义。基于我们对紫杉醇化学的研究,本综述总结了紫杉醇类似物在设计、合成和生物活性方面的最新进展,这可能会吸引药物化学和肿瘤学领域的研究人员。同时,这些新型化合物的巧妙设计、有趣的合成方法和潜在的生物活性也可能为更广泛的科学界提供有价值的参考。

相似文献

1
Recent advances in design, synthesis and bioactivity of paclitaxel-mimics.紫杉醇类似物的设计、合成及生物活性研究新进展
Fitoterapia. 2016 Apr;110:26-37. doi: 10.1016/j.fitote.2016.02.010. Epub 2016 Feb 22.
2
Chemistry and chemical biology of taxane anticancer agents.紫杉烷类抗癌药物的化学与化学生物学
Chem Rec. 2001;1(3):195-211. doi: 10.1002/tcr.1008.
3
Overcoming multidrug resistance in taxane chemotherapy.克服紫杉烷化疗中的多药耐药性。
Clin Chem Lab Med. 2002 Sep;40(9):918-25. doi: 10.1515/CCLM.2002.161.
4
General and recent aspects of the chemistry and structure-activity relationships of taxoids.紫杉烷类化合物的化学及构效关系的一般和最新研究进展
Curr Pharm Des. 2001 Sep;7(13):1229-49. doi: 10.2174/1381612013397429.
5
Medicinal chemistry of paclitaxel and its analogues.紫杉醇及其类似物的药物化学。
Curr Med Chem. 2009;16(30):3966-85. doi: 10.2174/092986709789352277.
6
Progress in the development of alternative pharmaceutical formulations of taxanes.紫杉烷类药物替代剂型的研发进展。
Invest New Drugs. 2001 May;19(2):143-53. doi: 10.1023/a:1010682916808.
7
Biological activity and chemistry of taxoids from the Japanese yew, Taxus cuspidata.日本红豆杉(东北红豆杉)中紫杉烷类化合物的生物活性与化学性质
J Nat Prod. 2004 Feb;67(2):245-56. doi: 10.1021/np030346y.
8
Design, synthesis and biological evaluation of paclitaxel-mimics possessing only the oxetane D-ring and side chain structures.仅具有环氧乙烷 D 环和侧链结构的紫杉醇类似物的设计、合成与生物评价。
Fitoterapia. 2014 Jan;92:111-5. doi: 10.1016/j.fitote.2013.10.015. Epub 2013 Nov 6.
9
Synthesis and structure-activity relationships of nonaromatic taxoids: effects of alkyl and alkenyl ester groups on cytotoxicity.非芳香类紫杉烷的合成及其构效关系:烷基和烯基酯基对细胞毒性的影响
J Med Chem. 1997 Jan 31;40(3):279-85. doi: 10.1021/jm9606711.
10
Clinical overview of the taxanes.紫杉烷类药物的临床概述。
Pharmacotherapy. 1997 Sep-Oct;17(5 Pt 2):110S-125S.

引用本文的文献

1
Formulation and evaluation of cetuximab functionalized phospholipid modified nanocrystals of paclitaxel for non-small cell lung cancer therapy.制备和评价西妥昔单抗功能化的紫杉醇磷脂纳米晶用于非小细胞肺癌的治疗。
Sci Rep. 2024 Nov 24;14(1):29114. doi: 10.1038/s41598-024-80283-8.
2
Substances of Natural Origin in Medicine: Plants vs. Cancer.天然药物中的物质:植物与癌症的较量。
Cells. 2023 Mar 23;12(7):986. doi: 10.3390/cells12070986.
3
Transcription level differences in var. elicited by Ce, Ce and methyl jasmonate.铈、铈和茉莉酸甲酯引发的变种中的转录水平差异。
Front Plant Sci. 2022 Nov 10;13:1040596. doi: 10.3389/fpls.2022.1040596. eCollection 2022.
4
Application of Nanoparticles in the Treatment of Lung Cancer With Emphasis on Receptors.纳米颗粒在肺癌治疗中的应用:以受体为重点
Front Pharmacol. 2022 Jan 10;12:781425. doi: 10.3389/fphar.2021.781425. eCollection 2021.
5
Recent Advances of Taxol-Loaded Biocompatible Nanocarriers Embedded in Natural Polymer-Based Hydrogels.负载紫杉醇的生物相容性纳米载体嵌入天然聚合物基水凝胶的最新进展
Gels. 2021 Mar 24;7(2):33. doi: 10.3390/gels7020033.
6
Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation.植物源天然产物在癌症研究中的应用:提取、作用机制和药物制剂。
Molecules. 2020 Nov 14;25(22):5319. doi: 10.3390/molecules25225319.
7
Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro.高效且肿瘤特异性敲低 MTDH 基因可减弱乳腺癌细胞在体内和体外对紫杉醇的耐药性。
Breast Cancer Res. 2018 Sep 18;20(1):113. doi: 10.1186/s13058-018-1042-7.
8
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application.植物次生代谢产物作为抗癌剂:临床试验和治疗应用的成功。
Int J Mol Sci. 2018 Jan 16;19(1):263. doi: 10.3390/ijms19010263.
9
Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes.靶向应激癌蛋白LEDGF/p75使化疗耐药的前列腺癌细胞对紫杉烷类药物敏感。
Oncotarget. 2017 Apr 11;8(15):24915-24931. doi: 10.18632/oncotarget.15323.
10
Emerging Cytotoxic Alkaloids in the Battle against Cancer: Overview of Molecular Mechanisms.抗癌斗争中新兴的细胞毒性生物碱:分子机制概述
Molecules. 2017 Feb 8;22(2):250. doi: 10.3390/molecules22020250.